Economic evaluation studies are now very important in the relationship between the pharmaceutical industry and the regulators. In addition, it is also essential to analyse return on investment in research and development, as it influences decisions on new drugs or therapeutic strategies.

Eurotrials’ Pharmacoeconomics Department has a wide range of services and multidisciplinary competences for these studies. It is able to answer all economic questions regarding submissions to the health authorities in accordance with methodological guidelines.